Applicant, as named in the Orange Book

Bayer Healthcare

Next listed expiry: Lampit on 6 Aug 2027. 5 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Lampit · 2 strengths nifurtimox	nifurtimox	213464	6 Aug 2027	exclusivity
Vitrakvi larotrectinib sulfate	larotrectinib sulfate	211710	16 May 2037	patent, carve-out possible
Ambelvist · 6 strengths gadoquatrane	gadoquatrane	219627	19 May 2040	patent
Nubeqa darolutamide	darolutamide	212099	17 Jun 2042	patent
Hyrnuo sevabertinib	sevabertinib	219972	14 Nov 2043	patent